DBV Technologies S.A - Stock Price History | DBVT

Historical daily share price chart and data for DBV Technologies S.A since 2020 adjusted for splits. The latest closing stock price for DBV Technologies S.A as of May 22, 2020 is 4.50.
  • The all-time high DBV Technologies S.A stock closing price was 49.36 on October 11, 2017.
  • The DBV Technologies S.A 52-week high stock price is 13.49, which is 199.8% above the current share price.
  • The DBV Technologies S.A 52-week low stock price is 2.02, which is 55.1% below the current share price.
  • The average DBV Technologies S.A stock price for the last 52 weeks is 8.25.
DBV Technologies S.A Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 8.5245 6.9900 11.1500 5.8100 10.7000 66.67%
2018 20.6314 25.4600 26.6000 5.7500 6.4200 -73.90%
2017 35.2508 34.7300 49.3600 20.9000 24.6000 -29.97%
2016 32.8193 35.4000 37.6700 23.0200 35.1300 -3.25%
2015 31.0632 28.2000 44.3700 20.6200 36.3100 33.89%
2014 25.7196 22.9000 28.5000 22.9000 27.1200 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.494B $0.015B
DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut. The Company delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin. DBV Technologies SA is headquartered in Bagneux, France.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $133.197B 14.66
Gilead Sciences (GILD) United States $91.996B 11.93
CSL (CSLLY) Australia $87.164B 0.00
Vertex Pharmaceuticals (VRTX) United States $73.883B 50.79
Regeneron Pharmaceuticals (REGN) United States $62.700B 24.17
Illumina (ILMN) United States $52.141B 53.58
Biogen (BIIB) United States $49.695B 8.51
Seattle Genetics (SGEN) United States $26.964B 0.00
Moderna (MRNA) United States $25.614B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.414B 9.63
Incyte (INCY) United States $21.600B 0.00
Genmab (GMAB) Denmark $19.127B 15.75
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Genmab (GNMSF) Denmark $17.896B 53.13
BioMarin Pharmaceutical (BMRN) United States $17.633B 159.85
Alnylam Pharmaceuticals (ALNY) United States $16.134B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $12.977B 38.43
Exact Sciences (EXAS) United States $12.517B 0.00
BeiGene (BGNE) Cayman Islands $12.307B 0.00
Sarepta Therapeutics (SRPT) United States $11.745B 0.00
BioNTech SE (BNTX) Germany $11.546B 0.00
Bio-Techne Corp (TECH) United States $10.183B 67.27
QIAGEN (QGEN) Netherlands $9.791B 28.47
Horizon Therapeutics Public (HZNP) Ireland $9.455B 23.27
Guardant Health (GH) United States $9.166B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.986B 0.00
Immunomedics (IMMU) United States $7.959B 0.00
Exelixis (EXEL) United States $7.550B 26.47
Repligen (RGEN) United States $7.297B 127.99
Ascendis Pharma (ASND) Denmark $7.032B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.759B 0.00
Reata Pharmaceuticals (RETA) United States $5.318B 0.00
Acceleron Pharma (XLRN) United States $5.307B 0.00
Adaptive Biotechnologies (ADPT) United States $5.295B 0.00
MyoKardia (MYOK) United States $5.018B 0.00
Mirati Therapeutics (MRTX) United States $4.435B 0.00
Emergent Biosolutions (EBS) United States $4.435B 29.07
Ultragenyx Pharmaceutical (RARE) United States $4.403B 0.00
MorphoSys AG (MOR) Germany $4.291B 33.29
CRISPR Therapeutics AG (CRSP) Switzerland $4.268B 93.25
China Biologic Products (CBPO) China $4.239B 23.57
Global Blood Therapeutics (GBT) United States $4.230B 0.00
Vir Biotechnology (VIR) United States $3.972B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.855B 0.00
Bluebird Bio (BLUE) United States $3.716B 0.00
Zai Lab (ZLAB) China $3.690B 0.00
Blueprint Medicines (BPMC) United States $3.532B 0.00
Halozyme Therapeutics (HALO) United States $3.341B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.309B 0.00
Amicus Therapeutics (FOLD) United States $3.267B 0.00
Viela Bio (VIE) United States $3.071B 0.00
NeoGenomics (NEO) United States $2.968B 216.77
Arena Pharmaceuticals (ARNA) United States $2.965B 0.00
UniQure (QURE) Netherlands $2.823B 0.00
Amarin (AMRN) Ireland $2.791B 0.00
Fate Therapeutics (FATE) United States $2.737B 0.00
Denali Therapeutics (DNLI) United States $2.688B 0.00
Alkermes (ALKS) Ireland $2.676B 52.69
Novavax (NVAX) United States $2.672B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.652B 0.00
Alector (ALEC) United States $2.616B 0.00
Insmed (INSM) United States $2.592B 0.00
Inovio Pharmaceuticals (INO) United States $2.226B 0.00
Principia Biopharma (PRNB) United States $2.148B 0.00
Epizyme (EPZM) United States $1.878B 0.00
Ligand Pharmaceuticals (LGND) United States $1.744B 67.90
Eidos Therapeutics (EIDX) United States $1.734B 0.00
Arvinas (ARVN) United States $1.724B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.707B 0.00
Editas Medicine (EDIT) United States $1.655B 0.00
Arcus Biosciences (RCUS) United States $1.648B 0.00
Zymeworks (ZYME) Canada $1.647B 0.00
Adverum Biotechnologies (ADVM) United States $1.644B 0.00
Sangamo Therapeutics (SGMO) United States $1.622B 0.00
REGENXBIO (RGNX) United States $1.618B 0.00
Twist Bioscience (TWST) United States $1.617B 0.00
Intra-Cellular Therapies (ITCI) United States $1.489B 0.00
Akcea Therapeutics (AKCA) United States $1.482B 0.00
Mesoblast (MESO) Australia $1.412B 0.00
PHARMA MAR SA (PHMMF) Spain $1.394B 0.00
NGM Biopharmaceuticals (NGM) United States $1.378B 0.00
Beam Therapeutics (BEAM) United States $1.319B 0.00
Cytokineticsorporated (CYTK) United States $1.303B 0.00
Zealand Pharma (ZEAL) Denmark $1.290B 0.00
I-Mab (IMAB) China $1.215B 0.00
Revance Therapeutics (RVNC) United States $1.212B 0.00
Coherus BioSciences (CHRS) United States $1.212B 8.46
Alcobra (ARCT) United States $1.159B 0.00
Myriad Genetics (MYGN) United States $1.098B 56.65
Intellia Therapeutics (NTLA) United States $1.078B 0.00
Sorrento Therapeutics (SRNE) United States $1.063B 0.00
Compugen (CGEN) Israel $0.979B 0.00
Pharming Group (PHGUF) Netherlands $0.939B 0.00
NextCure (NXTC) United States $0.911B 0.00
Athenex (ATNX) United States $0.908B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.907B 0.00
Cellectis S.A (CLLS) France $0.893B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Cue Biopharma (CUE) United States $0.856B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.773B 0.00
Cara Therapeutics (CARA) United States $0.770B 0.00
Heska (HSKA) United States $0.767B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.751B 0.00
Kadmon Holdings (KDMN) United States $0.746B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.733B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.724B 0.00
Retrophin (RTRX) United States $0.719B 0.00
Kala Pharmaceuticals (KALA) United States $0.714B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.700B 0.00
Codexis (CDXS) United States $0.662B 0.00
Castle Biosciences (CSTL) United States $0.653B 0.00
Vericel (VCEL) United States $0.643B 118.83
Morphic Holding (MORF) United States $0.640B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Stemline Therapeutics (STML) United States $0.625B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.620B 5.31
Bellus Health (BLU) Canada $0.620B 0.00
Frequency Therapeutics (FREQ) United States $0.612B 0.00
Athersys (ATHX) United States $0.601B 0.00
Mersana Therapeutics (MRSN) United States $0.584B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.578B 0.00
MeiraGTx Holdings (MGTX) United States $0.576B 0.00
VBI Vaccines (VBIV) United States $0.567B 0.00
Scholar Rock Holding (SRRK) United States $0.555B 0.00
NantKwest (NK) United States $0.550B 0.00
AnaptysBio (ANAB) United States $0.542B 0.00
Clovis Oncology (CLVS) United States $0.539B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
UROGEN PHARMA (URGN) United States $0.531B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.521B 0.00
AC Immune SA (ACIU) Switzerland $0.503B 0.00
BioDelivery Sciences (BDSI) United States $0.493B 25.97
Aquinox Pharmaceuticals (NLTX) United States $0.493B 0.00
Prothena (PRTA) Ireland $0.474B 0.00
Anika Therapeutics (ANIK) United States $0.474B 15.24
Dynavax Technologies (DVAX) United States $0.473B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.464B 0.00
Puma Biotechnology (PBYI) United States $0.461B 0.00
Merus (MRUS) Netherlands $0.440B 0.00
Intrexon (PGEN) United States $0.439B 0.00
Protagonist Therapeutics (PTGX) United States $0.435B 0.00
Syros Pharmaceuticals (SYRS) United States $0.430B 0.00
CytomX Therapeutics (CTMX) United States $0.426B 0.00
MiMedx (MDXG) United States $0.419B 0.00
Agenus (AGEN) United States $0.418B 0.00
Seres Therapeutics (MCRB) United States $0.401B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.396B 0.00
WAVE Life Sciences (WVE) Singapore $0.387B 0.00
PDL BioPharma (PDLI) United States $0.386B 331.00
Albireo Pharma (ALBO) United States $0.383B 0.00
ANI Pharmaceuticals (ANIP) United States $0.382B 7.57
Kamada (KMDA) Israel $0.382B 15.89
Precision BioSciences (DTIL) United States $0.381B 0.00
Geron (GERN) United States $0.369B 0.00
Selecta Biosciences (SELB) United States $0.343B 0.00
MannKind (MNKD) United States $0.320B 0.00
Menlo Therapeutics (MNLO) United States $0.305B 0.00
Verastem (VSTM) United States $0.302B 0.00
Avid Bioservices (CDMO) United States $0.299B 0.00
ChromaDex (CDXC) United States $0.298B 0.00
Cellular Biomedicine (CBMG) United States $0.288B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.273B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.272B 0.00
Abeona Therapeutics (ABEO) United States $0.270B 0.00
Starpharma Holdings (SPHRY) Australia $0.268B 0.00
Aduro Biotech (ADRO) United States $0.263B 0.00
Spero Therapeutics (SPRO) United States $0.257B 0.00
Gritstone Oncology (GRTS) United States $0.251B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.245B 0.00
Exicure (XCUR) United States $0.241B 0.00
Liquidia Technologies (LQDA) United States $0.239B 0.00
XOMA (XOMA) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.233B 0.00
OSMOTICA PHARM (OSMT) United States $0.230B 0.00
Northwest Biotherapeutics (NWBO) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.229B 0.00
Affimed (AFMD) Germany $0.228B 0.00
HOOKIPA Pharma (HOOK) United States $0.224B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.215B 3.24
IVERIC Bio (ISEE) United States $0.213B 0.00
Pluristem Therapeutics (PSTI) Israel $0.209B 0.00
ARAVIVE, INC (ARAV) United States $0.204B 0.00
Kindred Biosciences (KIN) United States $0.201B 0.00
Strongbridge Biopharma (SBBP) United States $0.201B 0.00
Five Prime Therapeutics (FPRX) United States $0.199B 0.00
VTv Therapeutics (VTVT) United States $0.198B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.197B 0.00
Prometic Life Sciences (LMNL) Canada $0.195B 0.00
Aptinyx (APTX) United States $0.192B 0.00
Aytu Bioscience (AYTU) United States $0.182B 0.00
Dyadic (DYAI) United States $0.165B 0.00
TELA Bio (TELA) United States $0.164B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.161B 0.00
Orgenesis (ORGS) United States $0.160B 0.00
Theratechnologies (THTX) Canada $0.159B 0.00
Arbutus Biopharma (ABUS) Canada $0.158B 0.00
Biofrontera AG (BFRA) Germany $0.155B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.152B 0.00
Antibe Therapeutics (ATBPF) Canada $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Enzo Biochem (ENZ) United States $0.144B 0.00
Trevena (TRVN) United States $0.144B 0.00
Cerecor (CERC) United States $0.142B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
AIT Therapeutics (XAIR) United States $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.128B 0.00
Checkpoint Therapeutics (CKPT) United States $0.125B 0.00
Cyclerion Therapeutics (CYCN) United States $0.119B 0.00
Applied Genetic Technologies (AGTC) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.118B 0.00
Lumos Pharma (LUMO) United States $0.116B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.110B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.110B 0.00
Windtree Therapeutics (WINT) United States $0.107B 0.00
Eton Pharmaceuticals (ETON) United States $0.100B 0.00
Organovo Holdings (ONVO) United States $0.097B 0.00
Catalyst Biosciences (CBIO) United States $0.091B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Clearside Biomedical (CLSD) United States $0.089B 0.00
Celsion (CLSN) United States $0.089B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.086B 0.00
Proteostasis Therapeutics (PTI) United States $0.085B 0.00
Adocia (ADOCY) France $0.080B 0.00
Stealth BioTherapeutics (MITO) United States $0.078B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.075B 0.00
Happiness Biotech Group (HAPP) China $0.070B 0.00
Oncobiologics (OTLK) United States $0.068B 0.00
Emmaus Life Sciences (EMMA) United States $0.067B 0.00
DiaMedica Therapeutics (DMAC) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Apricus Biosciences (SEEL) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
Soligenix (SNGX) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Celldex Therapeutics (CLDX) United States $0.051B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Pulmatrix (PULM) United States $0.048B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.046B 0.00
Advaxis (ADXS) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
Cesca Therapeutics (THMO) United States $0.041B 0.00
Chanticleer Holdings (SONN) United States $0.039B 0.00
ATyr Pharma (LIFE) United States $0.039B 0.00
OvaScience (MLND) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
TOCAGEN INC (TOCA) United States $0.036B 0.00
Signal Genetics (MGEN) United States $0.033B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.032B 0.00
Curis (CRIS) United States $0.030B 0.00
Evogene (EVGN) Israel $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
TrovaGene (CRDF) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
VIVUS (VVUS) United States $0.021B 0.00
Aptevo Therapeutics (APVO) United States $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00